Dr. Bryan Hartley

Well, the interesting thing is that we developed a technology to solve for chronic or recurrent urinary tract infection. Okay. We accidentally created a platform for drug delivery into the bladder that should work for any disease where you need to deliver drug into the bladder. So you can expand into overactive bladder or bladder cancer. Our reason we exist is for recurrent UTI.

Well, the interesting thing is that we developed a technology to solve for chronic or recurrent urinary tract infection. Okay. We accidentally created a platform for drug delivery into the bladder that should work for any disease where you need to deliver drug into the bladder. So you can expand into overactive bladder or bladder cancer. Our reason we exist is for recurrent UTI.

Well, the interesting thing is that we developed a technology to solve for chronic or recurrent urinary tract infection. Okay. We accidentally created a platform for drug delivery into the bladder that should work for any disease where you need to deliver drug into the bladder. So you can expand into overactive bladder or bladder cancer. Our reason we exist is for recurrent UTI.

And so that's our lead indication. But we've explored these other indications as well. All right, sweet.

And so that's our lead indication. But we've explored these other indications as well. All right, sweet.

And so that's our lead indication. But we've explored these other indications as well. All right, sweet.

Oh, we are. We've met with the FDA to understand our path forward and we have an opportunity to get an IND and then do phase two clinical trial. So we're raising a series A for that now.

Oh, we are. We've met with the FDA to understand our path forward and we have an opportunity to get an IND and then do phase two clinical trial. So we're raising a series A for that now.

Oh, we are. We've met with the FDA to understand our path forward and we have an opportunity to get an IND and then do phase two clinical trial. So we're raising a series A for that now.

So not everybody has a year to take off from their life to go to Stanford to do their biodesign program. So there is a need for the ability to learn what you're going to learn quickly. That's what books are for. The other need was that biodesign program's really built for entrepreneurs who are going to kind of give up everything they're doing and pursue that path.

So not everybody has a year to take off from their life to go to Stanford to do their biodesign program. So there is a need for the ability to learn what you're going to learn quickly. That's what books are for. The other need was that biodesign program's really built for entrepreneurs who are going to kind of give up everything they're doing and pursue that path.

So not everybody has a year to take off from their life to go to Stanford to do their biodesign program. So there is a need for the ability to learn what you're going to learn quickly. That's what books are for. The other need was that biodesign program's really built for entrepreneurs who are going to kind of give up everything they're doing and pursue that path.

But that's a different problem set and that's a different type of person than somebody who wants to do this part-time or somebody who already has a full-time job, whether it's in corporate or whether it's in a hospital. In those cases, you need to have something that will work in pieces. And there are certain things you have to prioritize that are different than at Biodesign.

But that's a different problem set and that's a different type of person than somebody who wants to do this part-time or somebody who already has a full-time job, whether it's in corporate or whether it's in a hospital. In those cases, you need to have something that will work in pieces. And there are certain things you have to prioritize that are different than at Biodesign.

But that's a different problem set and that's a different type of person than somebody who wants to do this part-time or somebody who already has a full-time job, whether it's in corporate or whether it's in a hospital. In those cases, you need to have something that will work in pieces. And there are certain things you have to prioritize that are different than at Biodesign.

Chief among them is early and quick results. And specifically in an environment where you have different resources available, you know, you're not a startup. And so that was the impetus behind the book, which was that when we would go and try to teach The important lessons we had learned at Stanford inside of a corporate environment, you know, it's just a different rule set.

Chief among them is early and quick results. And specifically in an environment where you have different resources available, you know, you're not a startup. And so that was the impetus behind the book, which was that when we would go and try to teach The important lessons we had learned at Stanford inside of a corporate environment, you know, it's just a different rule set.

Chief among them is early and quick results. And specifically in an environment where you have different resources available, you know, you're not a startup. And so that was the impetus behind the book, which was that when we would go and try to teach The important lessons we had learned at Stanford inside of a corporate environment, you know, it's just a different rule set.

So you had to you had to tweak the program quite a bit to make it successful. And we had to do it the same way every time. And so we thought, OK, this is a recurring problem. You should probably write it down and just make it easy for people. So that was the genesis of the book. And the philosophy behind it was, again, killing things quickly. So that's why we named the book Wombat.

So you had to you had to tweak the program quite a bit to make it successful. And we had to do it the same way every time. And so we thought, OK, this is a recurring problem. You should probably write it down and just make it easy for people. So that was the genesis of the book. And the philosophy behind it was, again, killing things quickly. So that's why we named the book Wombat.